2025年糖化血紅素檢測設備全球市場報告

近年來，糖化血紅素 (A1c) 檢測市場快速擴張，市場規模從 2024 年的 18.8 億美元成長至 2025 年的 20.8 億美元，複合年成長率達 10.3%。這段歷史時期的成長可歸因於整體糖尿病管理方案的趨勢、持續的技術創新、醫療基礎設施的改善、預防性護理實踐以及居家醫療。

預計未來幾年，糖化血紅蛋白 (A1c) 檢測市場將快速成長，到 2029 年將達到 32 億美元，年複合成長率（CAGR）為 11.4%。預測期內的成長可歸因於就地檢驗、家庭檢測和自我監測的普及、對預防性醫療保健的重視、人口老化以及醫療保健可近性的擴大。預測期內的主要趨勢包括持續創新和成本效益、糖尿病盛行率上升、向就地檢驗的轉變、技術進步以及居家醫療和自我監測。

糖化血紅蛋白 (HbA1c) 檢測儀是一種分析工具，用於量化糖化血紅蛋白 (HbA1c)。糖化血紅素是葡萄糖與血紅素結合形成糖化血紅素的過程，存在於個別血液樣本中。其目的是持續監測血糖值，並促進高效有效的糖尿病管理。

糖化血紅素 A1c 檢測儀主要有兩種：桌上型和手持式。桌上型設備設計用於方便在實驗室工作台上使用。桌上型糖化血紅素 A1c 檢測儀用於實驗室評估患者的血糖值，採用多種技術，包括離子交換高效液相層析法、免疫測量法、硼酸鹽親和層析法和直接酶聯免疫吸附法。這些技術廣泛應用於醫院、製藥公司、醫療設備和實驗室檢測。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供糖化血紅蛋白 (A1c) 檢測設備市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的糖化血紅蛋白 (A1c) 檢測設備細分市場、市場趨勢和商機，以及您在糖化血紅蛋白 (A1c) 行業取得成功所需的設備。本糖化血紅蛋白 (A1c) 檢測設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為11.4%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接波及美國，導致硼酸親和層析管柱和糖化血紅蛋白校準品的供應鏈中斷，這些產品主要來自加拿大和新加坡等主要地區，這可能導致糖尿病管理監測延遲和就地檢驗成本上升。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也可能更為廣泛。

糖尿病盛行率的不斷上升預計將推動糖化血紅蛋白 (A1c) 檢測市場的成長。糖尿病是一種以血糖值升高為特徵的慢性代謝性疾病。糖化血紅蛋白 (A1c) 檢測提供有關個人平均血糖值的重要資訊，並有助於診斷 2 型糖尿病、糖尿病前期和糖尿病管理。這使患者能夠監測自己的病情並做出明智的治療決策，以預防併發症。例如，2022 年，美國國家公共衛生組織疾病管制與預防中心報告稱，約有 3,730 萬人（占美國人口的 11.3%）患有糖尿病。因此，糖尿病患者數量的增加將刺激糖化血紅蛋白 (A1c) 檢測市場的成長。

預計照護現場檢驗 (POC) 的便利性將推動糖化血紅蛋白 (A1c) 檢測市場的發展。就地檢驗(POCT) 是指在病人的照護端進行的檢測。 POC 檢測的便利性提升，使醫療保健提供者能夠減少等待檢測結果的漫長時間，並提高患者滿意度。可攜式糖化血紅蛋白 (A1c) 檢測設備可以在診所、藥房甚至家庭等各種環境中提供快速準確的結果。例如，根據世界衛生組織 (WHO) 制定的標準，POC 診斷方法應易於使用且易於獲取，不僅適合實驗室負責人使用，也適合其他接受 POC 檢測基本培訓的醫療專業人員使用。因此， 照護現場檢測的便利性提升將有助於糖化血紅蛋白 (A1c) 檢測市場的成長。

糖化血紅蛋白 A1c 檢測設備市場涵蓋自動化、半自動化和基於生物感測器的糖化血紅蛋白 A1c 檢測設備的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球糖化血紅素 A1c 檢測設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球糖化血紅素 A1c 檢測設備市場：成長率分析
• 全球糖化血紅素 A1c 檢測設備市場表現：規模與成長，2019-2024 年
• 全球糖化血紅素檢測設備市場預測：2024-2029年及2034年規模與成長
• 全球糖化血紅素 A1c 檢測設備：總潛在市場 (TAM)

第6章 市場細分

• 全球糖化血紅素 A1c 檢測設備市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 桌上型裝置
• 手持裝置
• 全球糖化血紅素 A1c 檢測設備市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 離子交換高效液相層析
• 免疫檢測
• 硼酸鹽親和層析法
• 直接酵素法
• 其他技術
• 全球糖化血紅蛋白 A1c 檢測設備市場：按最終用途、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 製藥
• 醫療設備
• 實驗室檢查
• 全球糖化血紅素 A1c 檢測設備市場：按桌上型設備細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 全自動糖化血紅素分析儀
• 實驗室級分析設備
• 多參數測試設備
• 全球糖化血紅素 A1c 檢測設備市場：按手持設備細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 可攜式糖化血紅素A1C測試儀
• 就地檢驗設備
• 智慧型手機綜合測試裝置

第7章 區域和國家分析

• 全球糖化血紅素 A1c 檢測設備市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球糖化血紅素 A1c 檢測設備市場：依國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 糖化血紅素檢測設備市場：競爭格局
• 糖化血紅素檢測設備市場：公司簡介
  • Arkray Inc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Polymer Technology Systems Inc Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
  • Menarini Group Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• F Hoffmann-La Roche AG
• Siemens Healthineers AG
• Tosoh Corporation
• Trinity Biotech plc
• Transasia Bio-Medicals Limited
• Beckman Coulter Inc
• Diazyme Laboratories Inc
• EKF Diagnostics Holdings plc
• HemoCue AB
• OSANG Healthcare Co Ltd
• Danaher
• Bayer AG
• Thermo Fisher Scientific Inc.
• PTS Diagnostics India Private Limited
• Nova Biomedical

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年糖化血紅素檢測設備市場：哪些國家將提供新機會
• 2029 年糖化血紅素檢測設備市場：細分市場帶來新機會
• 2029年糖化血紅素檢測設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

The hemoglobin A1c testing device serves as the analytical tool utilized in quantifying HbA1C. In this process, glucose binds to hemoglobin, forming glycated hemoglobin within an individual's blood sample. Its purpose is to monitor blood sugar levels consistently, contributing to efficient and effective diabetic management.

Two primary types of hemoglobin A1c testing devices exist, benchtop devices and handheld devices. Benchtop devices are designed for convenient usage on a laboratory workbench. Employed in laboratories to assess blood sugar levels in patients, benchtop hemoglobin A1c testing devices make use of various technologies such as ion exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. These technologies find application in hospitals, pharmaceuticals, medical devices, and laboratory testing.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemoglobin a1c testing devices market research report is one of a series of new reports from The Business Research Company that provides hemoglobin a1c testing devices market statistics, including hemoglobin a1c testing devices industry global market size, regional shares, competitors with a hemoglobin a1c testing devices market share, detailed hemoglobin a1c testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin a1c testing devices industry. This hemoglobin a1c testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemoglobin a1c testing devices market size has grown rapidly in recent years. It will grow from $1.88 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to holistic diabetes management programs, continuous innovation, improvement in healthcare infrastructure, preventive healthcare practices, home healthcare trends.

The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to point-of-care testing expansion, home testing and self-monitoring, focus on preventive healthcare, increasing aging population, healthcare accessibility expansion. Major trends in the forecast period include continuous innovation and cost efficiency, rising diabetes prevalence, shift towards point-of-care testing, technological advancements, home healthcare and self-monitoring.

The forecast of 11.4% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for boronate affinity chromatography columns and glycated hemoglobin calibrators, sourced from key regions such as Canada and Singapore, which could lead to slower diabetes management monitoring and increased point-of-care testing costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is anticipated to drive the growth of the hemoglobin A1C testing devices market. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels. Hemoglobin A1C testing provides crucial information regarding average blood glucose levels in individuals, aiding in the diagnosis of type 2 diabetes, pre-diabetes, and diabetes management. This enables individuals to monitor their condition and make informed treatment decisions to prevent complications. For instance, in 2022, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that approximately 37.3 million people, or 11.3% of the U.S. population, were affected by diabetes. Consequently, the rising number of diabetes patients will fuel the growth of the hemoglobin A1C testing devices market.

The easy accessibility of point-of-care (POC) tests is expected to boost the hemoglobin A1C testing devices market. Point-of-care testing (POCT) refers to testing conducted at the site where the patient receives medical care. With improved access to POC tests, healthcare providers can enhance patient satisfaction by reducing long wait times for test results. Portable hemoglobin A1C testing devices can deliver quick and accurate results in various settings, including doctors' offices, pharmacies, and even homes. For example, according to the standards set by the World Health Organization (WHO), POC diagnostics are user-friendly and readily accessible, suitable for use not only by laboratory personnel but also by other healthcare professionals with basic training in POC testing. Therefore, the increased accessibility of point-of-care (POC) tests will contribute to the growth of the hemoglobin A1C testing devices market.

Major companies in the hemoglobin A1C testing devices market are concentrating on developing innovative solutions, including at-home HbA1c test kits, to give patients greater control over their diabetes management. An at-home HbA1c test kit is a medical device that allows individuals to measure their hemoglobin A1c (HbA1c) levels conveniently at home. For example, in May 2022, OmegaQuant, LLC, a U.S.-based independent CLIA-certified laboratory, launched an innovative HbA1c test that enables users to monitor their blood sugar levels from home. This at-home testing kit allows individuals to collect a blood sample with a simple finger stick, providing insights into their average blood glucose levels over the past three months. The results indicate optimal ranges for healthy blood sugar management, empowering users to make informed dietary and lifestyle decisions.

Key companies in the hemoglobin A1C testing devices market are focusing on the integration of microfluidic immunofluorescence tests for hemoglobin A1C to enhance their market position. Microfluidic immunofluorescence (MIF) is a sophisticated technique that merges the principles of microfluidics and immunofluorescence to detect and quantify various biomarkers in biological samples. For instance, in May 2022, LumiraDx Limited, a London-based next-generation point-of-care diagnostics company, announced that its HbA1c test had received CE Marking. When utilized with the LumiraDx Platform, this test delivers results from a sample application in under seven minutes, allowing for rapid monitoring of diabetic patients and quick screening and identification of individuals at risk of developing the disease.

In October 2023, Abbott Laboratories, a U.S.-based medical device company, entered into a partnership with WW International. This collaboration integrates Abbott's FreeStyle Libre continuous glucose monitoring technology with WeightWatchers' diabetes-focused weight management program, offering real-time glucose insights and personalized nutritional guidance to help individuals with diabetes make informed dietary choices and improve both weight management and glycemic control. WW International, Inc. is a U.S.-based company that provides services for weight loss and maintenance, fitness, and mindset, including the comprehensive Weight Watchers diet program.

Major companies operating in the hemoglobin A1c testing devices market include Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Bayer AG, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.

North America was the largest region in the hemoglobin A1c testing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1c testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemoglobin a1c testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemoglobin A1c testing device market consists of sales of automated, semi-automated, and bio-sensor-based hemoglobin A1c testing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemoglobin A1c Testing Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemoglobin a1c testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemoglobin a1c testing devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c testing devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Bench Top Device; Handheld Device
• 2) By Technology: Ion-Exchange HPLC; Immunoassay; Boronate Affinity Chromatography; Direct Enzymatic Assay; Other Technologies
• 3) By End Use: Hospitals; Pharmaceuticals; Medical Devices; Laboratory Testing
• Subsegments:
• 1) By Bench Top Device: Automated Hemoglobin A1C Analyzers; Laboratory-Grade Analyzers; Multi-Parameter Testing Devices
• 2) By Handheld Device: Portable Hemoglobin A1C Testers; Point-Of-Care Testing Devices; Smartphone-Integrated Testing Devices
• Companies Mentioned: Arkray Inc; Abbott Laboratories; Polymer Technology Systems Inc; Bio-Rad Laboratories Inc; Menarini Group; F Hoffmann-La Roche AG; Siemens Healthineers AG; Tosoh Corporation; Trinity Biotech plc; Transasia Bio-Medicals Limited; Beckman Coulter Inc; Diazyme Laboratories Inc; EKF Diagnostics Holdings plc; HemoCue AB; OSANG Healthcare Co Ltd; Danaher; Bayer AG; Thermo Fisher Scientific Inc.; PTS Diagnostics India Private Limited; Nova Biomedical; Randox Laboratories Ltd.; ACON Laboratories Inc.; DiaSys Diagnostic Systems GmbH; Erba Mannheim; Green Cross Medical Science Corp.; Infopia Co. Ltd.; TaiDoc Technology Corporation; Werfen; Zhejiang Orient Gene Biotech Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemoglobin A1c Testing Devices Market Characteristics

3. Hemoglobin A1c Testing Devices Market Trends And Strategies

4. Hemoglobin A1c Testing Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemoglobin A1c Testing Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hemoglobin A1c Testing Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hemoglobin A1c Testing Devices Market Growth Rate Analysis
• 5.4. Global Hemoglobin A1c Testing Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hemoglobin A1c Testing Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hemoglobin A1c Testing Devices Total Addressable Market (TAM)

6. Hemoglobin A1c Testing Devices Market Segmentation

• 6.1. Global Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bench Top Device
• Handheld Device
• 6.2. Global Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ion-Exchange HPLC
• Immunoassay
• Boronate Affinity Chromatography
• Direct Enzymatic Assay
• Other Technologies
• 6.3. Global Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Pharmaceuticals
• Medical Devices
• Laboratory Testing
• 6.4. Global Hemoglobin A1c Testing Devices Market, Sub-Segmentation Of Bench Top Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Hemoglobin A1C Analyzers
• Laboratory-Grade Analyzers
• Multi-Parameter Testing Devices
• 6.5. Global Hemoglobin A1c Testing Devices Market, Sub-Segmentation Of Handheld Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Hemoglobin A1C Testers
• Point-Of-Care Testing Devices
• Smartphone-Integrated Testing Devices

7. Hemoglobin A1c Testing Devices Market Regional And Country Analysis

• 7.1. Global Hemoglobin A1c Testing Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hemoglobin A1c Testing Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemoglobin A1c Testing Devices Market

• 8.1. Asia-Pacific Hemoglobin A1c Testing Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemoglobin A1c Testing Devices Market

• 9.1. China Hemoglobin A1c Testing Devices Market Overview
• 9.2. China Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemoglobin A1c Testing Devices Market

• 10.1. India Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemoglobin A1c Testing Devices Market

• 11.1. Japan Hemoglobin A1c Testing Devices Market Overview
• 11.2. Japan Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemoglobin A1c Testing Devices Market

• 12.1. Australia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemoglobin A1c Testing Devices Market

• 13.1. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemoglobin A1c Testing Devices Market

• 14.1. South Korea Hemoglobin A1c Testing Devices Market Overview
• 14.2. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemoglobin A1c Testing Devices Market

• 15.1. Western Europe Hemoglobin A1c Testing Devices Market Overview
• 15.2. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemoglobin A1c Testing Devices Market

• 16.1. UK Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemoglobin A1c Testing Devices Market

• 17.1. Germany Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemoglobin A1c Testing Devices Market

• 18.1. France Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemoglobin A1c Testing Devices Market

• 19.1. Italy Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemoglobin A1c Testing Devices Market

• 20.1. Spain Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemoglobin A1c Testing Devices Market

• 21.1. Eastern Europe Hemoglobin A1c Testing Devices Market Overview
• 21.2. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemoglobin A1c Testing Devices Market

• 22.1. Russia Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemoglobin A1c Testing Devices Market

• 23.1. North America Hemoglobin A1c Testing Devices Market Overview
• 23.2. North America Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemoglobin A1c Testing Devices Market

• 24.1. USA Hemoglobin A1c Testing Devices Market Overview
• 24.2. USA Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemoglobin A1c Testing Devices Market

• 25.1. Canada Hemoglobin A1c Testing Devices Market Overview
• 25.2. Canada Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemoglobin A1c Testing Devices Market

• 26.1. South America Hemoglobin A1c Testing Devices Market Overview
• 26.2. South America Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemoglobin A1c Testing Devices Market

• 27.1. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemoglobin A1c Testing Devices Market

• 28.1. Middle East Hemoglobin A1c Testing Devices Market Overview
• 28.2. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemoglobin A1c Testing Devices Market

• 29.1. Africa Hemoglobin A1c Testing Devices Market Overview
• 29.2. Africa Hemoglobin A1c Testing Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hemoglobin A1c Testing Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hemoglobin A1c Testing Devices Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemoglobin A1c Testing Devices Market Competitive Landscape And Company Profiles

• 30.1. Hemoglobin A1c Testing Devices Market Competitive Landscape
• 30.2. Hemoglobin A1c Testing Devices Market Company Profiles
  • 30.2.1. Arkray Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Polymer Technology Systems Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Menarini Group Overview, Products and Services, Strategy and Financial Analysis

31. Hemoglobin A1c Testing Devices Market Other Major And Innovative Companies

• 31.1. F Hoffmann-La Roche AG
• 31.2. Siemens Healthineers AG
• 31.3. Tosoh Corporation
• 31.4. Trinity Biotech plc
• 31.5. Transasia Bio-Medicals Limited
• 31.6. Beckman Coulter Inc
• 31.7. Diazyme Laboratories Inc
• 31.8. EKF Diagnostics Holdings plc
• 31.9. HemoCue AB
• 31.10. OSANG Healthcare Co Ltd
• 31.11. Danaher
• 31.12. Bayer AG
• 31.13. Thermo Fisher Scientific Inc.
• 31.14. PTS Diagnostics India Private Limited
• 31.15. Nova Biomedical

32. Global Hemoglobin A1c Testing Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemoglobin A1c Testing Devices Market

34. Recent Developments In The Hemoglobin A1c Testing Devices Market

35. Hemoglobin A1c Testing Devices Market High Potential Countries, Segments and Strategies

• 35.1 Hemoglobin A1c Testing Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hemoglobin A1c Testing Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hemoglobin A1c Testing Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer